Edition:
United States

Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

108.10EUR
10:42am EDT
Change (% chg)

€-0.35 (-0.32%)
Prev Close
€108.45
Open
€108.65
Day's High
€109.45
Day's Low
€107.95
Volume
1,009,773
Avg. Vol
1,866,236
52-wk High
€112.00
52-wk Low
€83.45

Select another date:

Tue, Apr 11 2017

Drug companies try again to expose outside investors in mass torts case

Stymied in at least two previous attempts to expose outside investment in mass torts litigation, Johnson & Johnson – this time alongside Bayer – is once again asking a court to require plaintiffs to disclose whether litigation funders have an interest in their case.

BRIEF-Oncomed Pharmaceuticals announces Bayer terminates its option to license vantictumab or ipafricept

* Oncomed Pharmaceuticals announces Bayer terminates its option to license vantictumab or ipafricept

BRIEF-Bayer's Rivaroxaban better than Aspirin in venous thromboembolism trial

* Bayer's Rivaroxaban demonstrated superior protection against recurrent venous thromboembolism compared with Aspirin in Einstein choice study

Court upholds attorneys' fee award for Dow in patent fight with Bayer

Bayer AG's crop science division must cover attorneys' fees for a Dow Chemical Co subsidiary which it targeted with a frivolous patent infringement lawsuit, a federal appeals court has ruled.

BRIEF-Bayer says invests $8.1 mln in soybean advancement in the Midwest

* Bayer says invests $8.1 million in soybean advancement in the midwest

BRIEF-Bayer confirms planning to raise about $19 bln in equity

* Confirms planning to raise total of approx. $19 billion in equity to fund Monsanto deal

Bayer, Monsanto start $2.5 bln asset sale to get merger clearance - sources

FRANKFURT German drug and crop chemical maker Bayer and U.S. seeds company Monsanto are launching asset sales worth roughly $2.5 billion as they seek regulatory clearance for their $66 billion merger, people close to the matter said.

Bayer, Monsanto start $2.5 billion asset sale to get merger clearance: sources

FRANKFURT German drug and crop chemical maker Bayer and U.S. seeds company Monsanto are launching asset sales worth roughly $2.5 billion as they seek regulatory clearance for their $66 billion merger, people close to the matter said.

Bayer, Monsanto start $2.5 bln asset sale to get merger clearance - sources

FRANKFURT, March 9 German drug and crop chemical maker Bayer and U.S. seeds company Monsanto are launching asset sales worth roughly $2.5 billion as they seek regulatory clearance for their $66 billion merger, people close to the matter said.

Court affirms $456 million award for Bayer in Dow patent fight

A federal appeals court has affirmed an arbitration tribunal’s order that Dow Chemical Co’s agricultural subsidiary pay $456 million for violating a patent licensing agreement with a rival Bayer AG unit.

Select another date:

More From Around the Web